D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 84 Citations 36,202 207 World Ranking 234 National Ranking 117
Medicine D-index 93 Citations 38,116 269 World Ranking 5068 National Ranking 2852

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • DNA
  • Virus

Amalio Telenti mainly focuses on Immunology, Genetics, Virology, Acquired immunodeficiency syndrome and Internal medicine. Amalio Telenti works in the field of Immunology, namely Viral load. In his study, which falls under the umbrella issue of Genetics, Antibacterial agent, Polymerase chain reaction and Gene is strongly linked to Mycobacterium tuberculosis.

His Virology study combines topics in areas such as T cell, NK-92, Interleukin 12, Antibody and Chemokine receptor. His work on Sida as part of his general Acquired immunodeficiency syndrome study is frequently connected to International community, thereby bridging the divide between different branches of science. His Internal medicine research is multidisciplinary, incorporating perspectives in Endocrinology, Surgery, Gastroenterology, Efavirenz and Ritonavir.

His most cited work include:

  • Antiretroviral Treatment of Adult HIV Infection: 2012 Recommendations of the International Antiviral Society–USA Panel (2345 citations)
  • Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis. (1254 citations)
  • A Whole-Genome Association Study of Major Determinants for Host Control of HIV-1 (1068 citations)

What are the main themes of his work throughout his whole career to date?

His main research concerns Genetics, Virology, Immunology, Gene and Genome. His studies in Virology integrate themes in fields like Antibody, Monoclonal antibody and Antigen. His Immunology study combines topics from a wide range of disciplines, such as Internal medicine and Acquired immunodeficiency syndrome.

While the research belongs to areas of Internal medicine, Amalio Telenti spends his time largely on the problem of Efavirenz, intersecting his research to questions surrounding Reverse-transcriptase inhibitor, Lopinavir, Ritonavir, Nelfinavir and Indinavir. As part of his studies on Gene, Amalio Telenti often connects relevant subjects like Microbiology. His Genome research integrates issues from Exome sequencing and Computational biology.

He most often published in these fields:

  • Genetics (29.18%)
  • Virology (25.17%)
  • Immunology (23.61%)

What were the highlights of his more recent work (between 2015-2021)?

  • Genetics (29.18%)
  • Genome (14.70%)
  • Computational biology (10.24%)

In recent papers he was focusing on the following fields of study:

His primary scientific interests are in Genetics, Genome, Computational biology, Gene and Genomics. His study on Whole genome sequencing, Genome-wide association study, Retinitis pigmentosa and Allele frequency is often connected to Identification as part of broader study in Genetics. His Gene course of study focuses on Microbiology and Flora, Urine, 16S ribosomal RNA and Metagenomics.

His study explores the link between Transcriptome and topics such as Single cell sequencing that cross with problems in Virology. His work deals with themes such as Immunology and Intensive care medicine, which intersect with Disease. Amalio Telenti is involved in the study of Immunology that focuses on Immune system in particular.

Between 2015 and 2021, his most popular works were:

  • Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody. (585 citations)
  • Deep sequencing of 10,000 human genomes. (218 citations)
  • A primer on deep learning in genomics. (214 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • DNA
  • Virus

His scientific interests lie mostly in Virology, Gene, Genetics, Human genome and Genome. Amalio Telenti combines subjects such as Antibody and GTPase with his study of Virology. His research in Gene intersects with topics in Infectivity, Interferon, Guanosine and Effector.

His Genetics research is multidisciplinary, relying on both Disease and Metabolomics. The concepts of his Genome study are interwoven with issues in Contrast, Computational biology and Allele frequency. His Carcinogenesis study integrates concerns from other disciplines, such as Immunology and Metagenomics.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Antiretroviral Treatment of Adult HIV Infection: 2012 Recommendations of the International Antiviral Society–USA Panel

Huldrych F Gunthard;Judith A Aberg;Joseph J Eron;Jennifer Frances Hoy.
JAMA (2008)

2345 Citations

Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis

A Telenti;P Imboden;F Marchesi;L Matter.
The Lancet (1993)

1775 Citations

Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis.

A Telenti;F Marchesi;M Balz;F Bally.
Journal of Clinical Microbiology (1993)

1714 Citations

Genetic Variation in IL28B Is Associated With Chronic Hepatitis C and Treatment Failure: A Genome-Wide Association Study

Andri Rauch;Zoltán Kutalik;Zoltán Kutalik;Patrick Descombes;Tao Cai.
Gastroenterology (2010)

1400 Citations

The major genetic determinants of HIV-1 control affect HLA class I peptide presentation

Pereyra F;Jia X;McLaren Pj.
Science (2010)

1350 Citations

A Whole-Genome Association Study of Major Determinants for Host Control of HIV-1

Jacques Fellay;Kevin V. Shianna;Dongliang Ge;Sara Colombo.
Science (2007)

1307 Citations

Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study.

Gilbert Greub;Bruno Ledergerber;M. Battegay;P. Grob.
The Lancet (2000)

1209 Citations

Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients : a prospective cohort study

Bruno Ledergerber;Matthias Egger;Milos Opravil;Amalio Telenti.
The Lancet (1999)

1096 Citations

Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients.

Catia Marzolini;Amalio Telenti;Laurent A. Decosterd;Gilbert Greub.
AIDS (2001)

1048 Citations

Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody.

Dora Pinto;Young Jun Park;Martina Beltramello;Alexandra C. Walls.
Nature (2020)

903 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Amalio Telenti

Bruce D. Walker

Bruce D. Walker

Harvard University

Publications: 214

Huldrych F. Günthard

Huldrych F. Günthard

University of Zurich

Publications: 203

Matthias Cavassini

Matthias Cavassini

University of Lausanne

Publications: 201

Manuel Battegay

Manuel Battegay

University Hospital of Basel

Publications: 196

Enos Bernasconi

Enos Bernasconi

Universita della Svizzera Italiana

Publications: 196

Julio S. G. Montaner

Julio S. G. Montaner

University of British Columbia

Publications: 185

Robert S. Hogg

Robert S. Hogg

Simon Fraser University

Publications: 153

Mary Carrington

Mary Carrington

Ragon Institute of MGH, MIT and Harvard

Publications: 151

Bruno Ledergerber

Bruno Ledergerber

University of Zurich

Publications: 142

Hansjakob Furrer

Hansjakob Furrer

University of Bern

Publications: 139

Steven G. Deeks

Steven G. Deeks

University of California, San Francisco

Publications: 132

Rainer Weber

Rainer Weber

University of Zurich

Publications: 131

Jacques Fellay

Jacques Fellay

École Polytechnique Fédérale de Lausanne

Publications: 125

Vincent Soriano

Vincent Soriano

Hospital Universitario La Paz

Publications: 125

Andrew N. Phillips

Andrew N. Phillips

University College London

Publications: 121

Jens D. Lundgren

Jens D. Lundgren

Rigshospitalet

Publications: 110

Something went wrong. Please try again later.